Share on StockTwits

Skyline Medical (NASDAQ:SKLN) major shareholder Samuel Herschkowitz acquired 2,000 shares of Skyline Medical stock on the open market in a transaction dated Tuesday, August 19th. The stock was purchased at an average price of $0.12 per share, for a total transaction of $240.00. Following the acquisition, the insider now directly owns 46,782,377 shares in the company, valued at approximately $5,613,885. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Shares of Skyline Medical (NASDAQ:SKLN) remained flat at $0.1299 during during mid-day trading trading on Monday. Skyline Medical has a 1-year low of $0.106 and a 1-year high of $0.47. The stock’s 50-day moving average is $0.13 and its 200-day moving average is $0.17. The company’s market cap is $29.0 million.

Skyline Medical Inc, formerly BioDrain Medical, Inc, is an early stage medical device company. The Company owns patent rights to its products and will distribute its products to medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed.

Receive News & Ratings for Skyline Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skyline Medical Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.